Skip to main content

Table 2 Changes in disability (HAQ scores) by EULAR response mean scores (95 % confidence intervals)

From: Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?

  None Moderate Good Difference moderate and good
CARDERA 0.10 (–0.01, 0.21) –0.39 (–0.48, –0.30) –0.88 (–1.02, –0.73) –0.49 (–0.66, –0.32)
TACIT –0.04 (–0.15, 0.08) –0.33 (-0.44, -0.22) –0.64 (–0.77, –0.51) –0.30 (–0.47, –0.13)
  1. EULAR European League Against Rheumatism, CARDERA cost-effectiveness of treatment strategies using combination of disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis, TACIT tumour necrosis factor inhibitors against combination intensive therapy